Extendicare Inc. (TSE:EXE – Get Free Report) announced a monthly dividend on Monday, September 16th, Zacks reports. Stockholders of record on Monday, September 30th will be given a dividend of 0.04 per share on Tuesday, October 15th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 5.13%. The ex-dividend date of this dividend is Friday, September 27th.
Extendicare Stock Up 0.5 %
Shares of TSE:EXE opened at C$9.36 on Wednesday. The stock’s 50-day moving average is C$8.27 and its 200 day moving average is C$7.70. The company has a market cap of C$781.28 million, a PE ratio of 13.76 and a beta of 1.26. The company has a debt-to-equity ratio of 305.80, a current ratio of 0.60 and a quick ratio of 0.98. Extendicare has a 1 year low of C$5.75 and a 1 year high of C$9.52.
Extendicare (TSE:EXE – Get Free Report) last posted its earnings results on Monday, August 12th. The company reported C$0.29 earnings per share (EPS) for the quarter. Extendicare had a return on equity of 60.00% and a net margin of 4.28%. The firm had revenue of C$348.48 million for the quarter, compared to analysts’ expectations of C$360.20 million.
Analyst Upgrades and Downgrades
Read Our Latest Stock Analysis on EXE
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Featured Stories
- Five stocks we like better than Extendicare
- What is the NASDAQ Stock Exchange?
- Gold Rush Continues: Time to Buy More or Take Profits?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Is Rivian Stock a Bargain Buy With 60% Upside Potential?
- Why Invest in High-Yield Dividend Stocks?
- 4 Catalysts Poised to Push Caterpillar Stock to Record Highs
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.